All Inventions from Dr. Mark Connors

Replication-Competent Adenovirus Type 4 SARS-CoV-2 Vaccines and Their Use

Ref: E-055-2021-0 | Updated: Feb 19, 2021 | NIAID

Optimized Variants of the Broadly Neutralizing HIV-1 gp41 Antibody, 10E8

Ref: E-133-2015-0 | Updated: Nov 19, 2018 | NIAID

Broadly Neutralizing Antibodies Against HIV-1 Directed to the CD4 Binding Site of HIV Envelope Protein

Ref: E-300-2009-0 | Updated: Jun 22, 2018 | NIAID

N6, A Novel, Broad, Highly Potent HIV-specific Antibody

Ref: E-131-2015-0 | Updated: Mar 15, 2017 | NIAID

Broadly Neutralizing Human Anti-HIV Monoclonal Antibody 10E8 and Related Antibodies Capable of Neutralizing Most...

Ref: E-253-2011-0 | Updated: Jun 18, 2014 | NIAID

Find Technologies